Restoration of autophagy in endothelial cells from patients with diabetes mellitus improves nitric oxide signaling
Abstract Background Endothelial dysfunction contributes to cardiovascular disease in diabetes mellitus. Autophagy is a multistep mechanism for the removal of damaged proteins and organelles from the cell. Under diabetic conditions, inadequate autophagy promotes cellular dysfunction and insulin resis...
Gespeichert in:
Veröffentlicht in: | Atherosclerosis 2016-04, Vol.247, p.207-217 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 217 |
---|---|
container_issue | |
container_start_page | 207 |
container_title | Atherosclerosis |
container_volume | 247 |
creator | Fetterman, Jessica L Holbrook, Monica Flint, Nir Feng, Bihua Bretόn-Romero, Rosa Linder, Erika A Berk, Brittany D Duess, Mai-Ann Farb, Melissa G Gokce, Noyan Shirihai, Orian S Hamburg, Naomi M Vita, Joseph A |
description | Abstract Background Endothelial dysfunction contributes to cardiovascular disease in diabetes mellitus. Autophagy is a multistep mechanism for the removal of damaged proteins and organelles from the cell. Under diabetic conditions, inadequate autophagy promotes cellular dysfunction and insulin resistance in non-vascular tissue. We hypothesized that impaired autophagy contributes to endothelial dysfunction in diabetes mellitus. Methods and results We measured autophagy markers and endothelial nitric oxide synthase (eNOS) activation in freshly isolated endothelial cells from diabetic subjects (n = 45) and non-diabetic controls (n = 41). p62 levels were higher in cells from diabetics (34.2 ± 3.6 vs. 20.0 ± 1.6, P = 0.001), indicating reduced autophagic flux. Bafilomycin inhibited insulin-induced activation of eNOS (64.7 ± 22% to −47.8 ± 8%, P = 0.04) in cells from controls, confirming that intact autophagy is necessary for eNOS signaling. In endothelial cells from diabetics, activation of autophagy with spermidine restored eNOS activation, suggesting that impaired autophagy contributes to endothelial dysfunction (P = 0.01). Indicators of autophagy initiation including the number of LC3-bound puncta and beclin 1 expression were similar in diabetics and controls, whereas an autophagy terminal phase indicator, the lysosomal protein Lamp2a, was higher in diabetics. In endothelial cells under diabetic conditions, the beneficial effect of spermidine on eNOS activation was blocked by autophagy inhibitors bafilomycin or 3-methyladenine. Blocking the terminal stage of autophagy with bafilomycin increased p62 (P = 0.01) in cells from diabetics to a lesser extent than in cells from controls (P = 0.04), suggesting ongoing, but inadequate autophagic clearance. Conclusion Inadequate autophagy contributes to endothelial dysfunction in patients with diabetes and may be a target for therapy of diabetic vascular disease. |
doi_str_mv | 10.1016/j.atherosclerosis.2016.01.043 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4913892</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0021915016300429</els_id><sourcerecordid>1776086313</sourcerecordid><originalsourceid>FETCH-LOGICAL-c554t-945546423ac828a0ee6b08de0129ae0a403a04c33cfbf2981fb36300e859f4c13</originalsourceid><addsrcrecordid>eNqNkk1v1DAQhiMEotvCX0C-IHFJGH9sNjlQCVXQIlVC4uNsOc5kd5YkDrazZf89jrZU0BMXj2S_8-H3mSx7zaHgwMu3-8LEHXoXbL-cFAqRrgvgBSj5JFvxalPnXFXqabYCEDyv-RrOsvMQ9gCgNrx6np2JshZlCXyV-S8YovMmkhuZ65iZo5t2ZntkNDIcW5ea9WR6ZrHvA-u8G9iU1DjGwO4o7lhLpsGIgQ1JQXEOjIbJu0O6GSl6ssz9ohZZoO1oehq3L7JnnekDvryPF9n3jx--Xd3kt5-vP129v83teq1iXqsUSiWksZWoDCCWDVQtAhe1QTAKpAFlpbRd04m64l0jSwmA1brulOXyIrs81Z3mZsDWppG96fXkaTD-qJ0h_e_LSDu9dQetai6rWqQCb-4LePdzTj7pgcLigxnRzUHzzaaEqpRcJum7k9QmJsFj99CGg1646b1-xE0v3DRwnbil_Fd_z_qQ_QdUElyfBJgcOxB6HWyCYLEljzbq1tF_t7p8VMkmKmRN_wOPGPZu9olT-p0OQoP-uizRskN8MVeJWv4GYcTMRw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1776086313</pqid></control><display><type>article</type><title>Restoration of autophagy in endothelial cells from patients with diabetes mellitus improves nitric oxide signaling</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Fetterman, Jessica L ; Holbrook, Monica ; Flint, Nir ; Feng, Bihua ; Bretόn-Romero, Rosa ; Linder, Erika A ; Berk, Brittany D ; Duess, Mai-Ann ; Farb, Melissa G ; Gokce, Noyan ; Shirihai, Orian S ; Hamburg, Naomi M ; Vita, Joseph A</creator><creatorcontrib>Fetterman, Jessica L ; Holbrook, Monica ; Flint, Nir ; Feng, Bihua ; Bretόn-Romero, Rosa ; Linder, Erika A ; Berk, Brittany D ; Duess, Mai-Ann ; Farb, Melissa G ; Gokce, Noyan ; Shirihai, Orian S ; Hamburg, Naomi M ; Vita, Joseph A</creatorcontrib><description>Abstract Background Endothelial dysfunction contributes to cardiovascular disease in diabetes mellitus. Autophagy is a multistep mechanism for the removal of damaged proteins and organelles from the cell. Under diabetic conditions, inadequate autophagy promotes cellular dysfunction and insulin resistance in non-vascular tissue. We hypothesized that impaired autophagy contributes to endothelial dysfunction in diabetes mellitus. Methods and results We measured autophagy markers and endothelial nitric oxide synthase (eNOS) activation in freshly isolated endothelial cells from diabetic subjects (n = 45) and non-diabetic controls (n = 41). p62 levels were higher in cells from diabetics (34.2 ± 3.6 vs. 20.0 ± 1.6, P = 0.001), indicating reduced autophagic flux. Bafilomycin inhibited insulin-induced activation of eNOS (64.7 ± 22% to −47.8 ± 8%, P = 0.04) in cells from controls, confirming that intact autophagy is necessary for eNOS signaling. In endothelial cells from diabetics, activation of autophagy with spermidine restored eNOS activation, suggesting that impaired autophagy contributes to endothelial dysfunction (P = 0.01). Indicators of autophagy initiation including the number of LC3-bound puncta and beclin 1 expression were similar in diabetics and controls, whereas an autophagy terminal phase indicator, the lysosomal protein Lamp2a, was higher in diabetics. In endothelial cells under diabetic conditions, the beneficial effect of spermidine on eNOS activation was blocked by autophagy inhibitors bafilomycin or 3-methyladenine. Blocking the terminal stage of autophagy with bafilomycin increased p62 (P = 0.01) in cells from diabetics to a lesser extent than in cells from controls (P = 0.04), suggesting ongoing, but inadequate autophagic clearance. Conclusion Inadequate autophagy contributes to endothelial dysfunction in patients with diabetes and may be a target for therapy of diabetic vascular disease.</description><identifier>ISSN: 0021-9150</identifier><identifier>EISSN: 1879-1484</identifier><identifier>DOI: 10.1016/j.atherosclerosis.2016.01.043</identifier><identifier>PMID: 26926601</identifier><language>eng</language><publisher>Ireland: Elsevier Ireland Ltd</publisher><subject>Adenosine - analogs & derivatives ; Adenosine - pharmacology ; Adult ; Aged ; Autophagy ; Autophagy - drug effects ; Biomarkers - metabolism ; Cardiovascular ; Case-Control Studies ; Cell Separation - methods ; Cells, Cultured ; Diabetes mellitus ; Diabetes Mellitus, Type 2 - blood ; Diabetes Mellitus, Type 2 - drug therapy ; Diabetes Mellitus, Type 2 - pathology ; Diabetes Mellitus, Type 2 - physiopathology ; Diabetic Angiopathies - blood ; Diabetic Angiopathies - pathology ; Diabetic Angiopathies - physiopathology ; Diabetic Angiopathies - prevention & control ; Endothelial cells ; Endothelial Cells - drug effects ; Endothelial Cells - metabolism ; Endothelial Cells - pathology ; Female ; Humans ; Macrolides - pharmacology ; Male ; Middle Aged ; Nitric Oxide - metabolism ; Nitric Oxide Synthase Type III - metabolism ; Signal Transduction - drug effects ; Spermidine - pharmacology</subject><ispartof>Atherosclerosis, 2016-04, Vol.247, p.207-217</ispartof><rights>Elsevier Ireland Ltd</rights><rights>2016 Elsevier Ireland Ltd</rights><rights>Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c554t-945546423ac828a0ee6b08de0129ae0a403a04c33cfbf2981fb36300e859f4c13</citedby><cites>FETCH-LOGICAL-c554t-945546423ac828a0ee6b08de0129ae0a403a04c33cfbf2981fb36300e859f4c13</cites><orcidid>0000-0002-9981-288X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0021915016300429$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26926601$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fetterman, Jessica L</creatorcontrib><creatorcontrib>Holbrook, Monica</creatorcontrib><creatorcontrib>Flint, Nir</creatorcontrib><creatorcontrib>Feng, Bihua</creatorcontrib><creatorcontrib>Bretόn-Romero, Rosa</creatorcontrib><creatorcontrib>Linder, Erika A</creatorcontrib><creatorcontrib>Berk, Brittany D</creatorcontrib><creatorcontrib>Duess, Mai-Ann</creatorcontrib><creatorcontrib>Farb, Melissa G</creatorcontrib><creatorcontrib>Gokce, Noyan</creatorcontrib><creatorcontrib>Shirihai, Orian S</creatorcontrib><creatorcontrib>Hamburg, Naomi M</creatorcontrib><creatorcontrib>Vita, Joseph A</creatorcontrib><title>Restoration of autophagy in endothelial cells from patients with diabetes mellitus improves nitric oxide signaling</title><title>Atherosclerosis</title><addtitle>Atherosclerosis</addtitle><description>Abstract Background Endothelial dysfunction contributes to cardiovascular disease in diabetes mellitus. Autophagy is a multistep mechanism for the removal of damaged proteins and organelles from the cell. Under diabetic conditions, inadequate autophagy promotes cellular dysfunction and insulin resistance in non-vascular tissue. We hypothesized that impaired autophagy contributes to endothelial dysfunction in diabetes mellitus. Methods and results We measured autophagy markers and endothelial nitric oxide synthase (eNOS) activation in freshly isolated endothelial cells from diabetic subjects (n = 45) and non-diabetic controls (n = 41). p62 levels were higher in cells from diabetics (34.2 ± 3.6 vs. 20.0 ± 1.6, P = 0.001), indicating reduced autophagic flux. Bafilomycin inhibited insulin-induced activation of eNOS (64.7 ± 22% to −47.8 ± 8%, P = 0.04) in cells from controls, confirming that intact autophagy is necessary for eNOS signaling. In endothelial cells from diabetics, activation of autophagy with spermidine restored eNOS activation, suggesting that impaired autophagy contributes to endothelial dysfunction (P = 0.01). Indicators of autophagy initiation including the number of LC3-bound puncta and beclin 1 expression were similar in diabetics and controls, whereas an autophagy terminal phase indicator, the lysosomal protein Lamp2a, was higher in diabetics. In endothelial cells under diabetic conditions, the beneficial effect of spermidine on eNOS activation was blocked by autophagy inhibitors bafilomycin or 3-methyladenine. Blocking the terminal stage of autophagy with bafilomycin increased p62 (P = 0.01) in cells from diabetics to a lesser extent than in cells from controls (P = 0.04), suggesting ongoing, but inadequate autophagic clearance. Conclusion Inadequate autophagy contributes to endothelial dysfunction in patients with diabetes and may be a target for therapy of diabetic vascular disease.</description><subject>Adenosine - analogs & derivatives</subject><subject>Adenosine - pharmacology</subject><subject>Adult</subject><subject>Aged</subject><subject>Autophagy</subject><subject>Autophagy - drug effects</subject><subject>Biomarkers - metabolism</subject><subject>Cardiovascular</subject><subject>Case-Control Studies</subject><subject>Cell Separation - methods</subject><subject>Cells, Cultured</subject><subject>Diabetes mellitus</subject><subject>Diabetes Mellitus, Type 2 - blood</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Diabetes Mellitus, Type 2 - pathology</subject><subject>Diabetes Mellitus, Type 2 - physiopathology</subject><subject>Diabetic Angiopathies - blood</subject><subject>Diabetic Angiopathies - pathology</subject><subject>Diabetic Angiopathies - physiopathology</subject><subject>Diabetic Angiopathies - prevention & control</subject><subject>Endothelial cells</subject><subject>Endothelial Cells - drug effects</subject><subject>Endothelial Cells - metabolism</subject><subject>Endothelial Cells - pathology</subject><subject>Female</subject><subject>Humans</subject><subject>Macrolides - pharmacology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Nitric Oxide - metabolism</subject><subject>Nitric Oxide Synthase Type III - metabolism</subject><subject>Signal Transduction - drug effects</subject><subject>Spermidine - pharmacology</subject><issn>0021-9150</issn><issn>1879-1484</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkk1v1DAQhiMEotvCX0C-IHFJGH9sNjlQCVXQIlVC4uNsOc5kd5YkDrazZf89jrZU0BMXj2S_8-H3mSx7zaHgwMu3-8LEHXoXbL-cFAqRrgvgBSj5JFvxalPnXFXqabYCEDyv-RrOsvMQ9gCgNrx6np2JshZlCXyV-S8YovMmkhuZ65iZo5t2ZntkNDIcW5ea9WR6ZrHvA-u8G9iU1DjGwO4o7lhLpsGIgQ1JQXEOjIbJu0O6GSl6ssz9ohZZoO1oehq3L7JnnekDvryPF9n3jx--Xd3kt5-vP129v83teq1iXqsUSiWksZWoDCCWDVQtAhe1QTAKpAFlpbRd04m64l0jSwmA1brulOXyIrs81Z3mZsDWppG96fXkaTD-qJ0h_e_LSDu9dQetai6rWqQCb-4LePdzTj7pgcLigxnRzUHzzaaEqpRcJum7k9QmJsFj99CGg1646b1-xE0v3DRwnbil_Fd_z_qQ_QdUElyfBJgcOxB6HWyCYLEljzbq1tF_t7p8VMkmKmRN_wOPGPZu9olT-p0OQoP-uizRskN8MVeJWv4GYcTMRw</recordid><startdate>20160401</startdate><enddate>20160401</enddate><creator>Fetterman, Jessica L</creator><creator>Holbrook, Monica</creator><creator>Flint, Nir</creator><creator>Feng, Bihua</creator><creator>Bretόn-Romero, Rosa</creator><creator>Linder, Erika A</creator><creator>Berk, Brittany D</creator><creator>Duess, Mai-Ann</creator><creator>Farb, Melissa G</creator><creator>Gokce, Noyan</creator><creator>Shirihai, Orian S</creator><creator>Hamburg, Naomi M</creator><creator>Vita, Joseph A</creator><general>Elsevier Ireland Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-9981-288X</orcidid></search><sort><creationdate>20160401</creationdate><title>Restoration of autophagy in endothelial cells from patients with diabetes mellitus improves nitric oxide signaling</title><author>Fetterman, Jessica L ; Holbrook, Monica ; Flint, Nir ; Feng, Bihua ; Bretόn-Romero, Rosa ; Linder, Erika A ; Berk, Brittany D ; Duess, Mai-Ann ; Farb, Melissa G ; Gokce, Noyan ; Shirihai, Orian S ; Hamburg, Naomi M ; Vita, Joseph A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c554t-945546423ac828a0ee6b08de0129ae0a403a04c33cfbf2981fb36300e859f4c13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adenosine - analogs & derivatives</topic><topic>Adenosine - pharmacology</topic><topic>Adult</topic><topic>Aged</topic><topic>Autophagy</topic><topic>Autophagy - drug effects</topic><topic>Biomarkers - metabolism</topic><topic>Cardiovascular</topic><topic>Case-Control Studies</topic><topic>Cell Separation - methods</topic><topic>Cells, Cultured</topic><topic>Diabetes mellitus</topic><topic>Diabetes Mellitus, Type 2 - blood</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Diabetes Mellitus, Type 2 - pathology</topic><topic>Diabetes Mellitus, Type 2 - physiopathology</topic><topic>Diabetic Angiopathies - blood</topic><topic>Diabetic Angiopathies - pathology</topic><topic>Diabetic Angiopathies - physiopathology</topic><topic>Diabetic Angiopathies - prevention & control</topic><topic>Endothelial cells</topic><topic>Endothelial Cells - drug effects</topic><topic>Endothelial Cells - metabolism</topic><topic>Endothelial Cells - pathology</topic><topic>Female</topic><topic>Humans</topic><topic>Macrolides - pharmacology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Nitric Oxide - metabolism</topic><topic>Nitric Oxide Synthase Type III - metabolism</topic><topic>Signal Transduction - drug effects</topic><topic>Spermidine - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fetterman, Jessica L</creatorcontrib><creatorcontrib>Holbrook, Monica</creatorcontrib><creatorcontrib>Flint, Nir</creatorcontrib><creatorcontrib>Feng, Bihua</creatorcontrib><creatorcontrib>Bretόn-Romero, Rosa</creatorcontrib><creatorcontrib>Linder, Erika A</creatorcontrib><creatorcontrib>Berk, Brittany D</creatorcontrib><creatorcontrib>Duess, Mai-Ann</creatorcontrib><creatorcontrib>Farb, Melissa G</creatorcontrib><creatorcontrib>Gokce, Noyan</creatorcontrib><creatorcontrib>Shirihai, Orian S</creatorcontrib><creatorcontrib>Hamburg, Naomi M</creatorcontrib><creatorcontrib>Vita, Joseph A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Atherosclerosis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fetterman, Jessica L</au><au>Holbrook, Monica</au><au>Flint, Nir</au><au>Feng, Bihua</au><au>Bretόn-Romero, Rosa</au><au>Linder, Erika A</au><au>Berk, Brittany D</au><au>Duess, Mai-Ann</au><au>Farb, Melissa G</au><au>Gokce, Noyan</au><au>Shirihai, Orian S</au><au>Hamburg, Naomi M</au><au>Vita, Joseph A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Restoration of autophagy in endothelial cells from patients with diabetes mellitus improves nitric oxide signaling</atitle><jtitle>Atherosclerosis</jtitle><addtitle>Atherosclerosis</addtitle><date>2016-04-01</date><risdate>2016</risdate><volume>247</volume><spage>207</spage><epage>217</epage><pages>207-217</pages><issn>0021-9150</issn><eissn>1879-1484</eissn><abstract>Abstract Background Endothelial dysfunction contributes to cardiovascular disease in diabetes mellitus. Autophagy is a multistep mechanism for the removal of damaged proteins and organelles from the cell. Under diabetic conditions, inadequate autophagy promotes cellular dysfunction and insulin resistance in non-vascular tissue. We hypothesized that impaired autophagy contributes to endothelial dysfunction in diabetes mellitus. Methods and results We measured autophagy markers and endothelial nitric oxide synthase (eNOS) activation in freshly isolated endothelial cells from diabetic subjects (n = 45) and non-diabetic controls (n = 41). p62 levels were higher in cells from diabetics (34.2 ± 3.6 vs. 20.0 ± 1.6, P = 0.001), indicating reduced autophagic flux. Bafilomycin inhibited insulin-induced activation of eNOS (64.7 ± 22% to −47.8 ± 8%, P = 0.04) in cells from controls, confirming that intact autophagy is necessary for eNOS signaling. In endothelial cells from diabetics, activation of autophagy with spermidine restored eNOS activation, suggesting that impaired autophagy contributes to endothelial dysfunction (P = 0.01). Indicators of autophagy initiation including the number of LC3-bound puncta and beclin 1 expression were similar in diabetics and controls, whereas an autophagy terminal phase indicator, the lysosomal protein Lamp2a, was higher in diabetics. In endothelial cells under diabetic conditions, the beneficial effect of spermidine on eNOS activation was blocked by autophagy inhibitors bafilomycin or 3-methyladenine. Blocking the terminal stage of autophagy with bafilomycin increased p62 (P = 0.01) in cells from diabetics to a lesser extent than in cells from controls (P = 0.04), suggesting ongoing, but inadequate autophagic clearance. Conclusion Inadequate autophagy contributes to endothelial dysfunction in patients with diabetes and may be a target for therapy of diabetic vascular disease.</abstract><cop>Ireland</cop><pub>Elsevier Ireland Ltd</pub><pmid>26926601</pmid><doi>10.1016/j.atherosclerosis.2016.01.043</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-9981-288X</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-9150 |
ispartof | Atherosclerosis, 2016-04, Vol.247, p.207-217 |
issn | 0021-9150 1879-1484 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4913892 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adenosine - analogs & derivatives Adenosine - pharmacology Adult Aged Autophagy Autophagy - drug effects Biomarkers - metabolism Cardiovascular Case-Control Studies Cell Separation - methods Cells, Cultured Diabetes mellitus Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - pathology Diabetes Mellitus, Type 2 - physiopathology Diabetic Angiopathies - blood Diabetic Angiopathies - pathology Diabetic Angiopathies - physiopathology Diabetic Angiopathies - prevention & control Endothelial cells Endothelial Cells - drug effects Endothelial Cells - metabolism Endothelial Cells - pathology Female Humans Macrolides - pharmacology Male Middle Aged Nitric Oxide - metabolism Nitric Oxide Synthase Type III - metabolism Signal Transduction - drug effects Spermidine - pharmacology |
title | Restoration of autophagy in endothelial cells from patients with diabetes mellitus improves nitric oxide signaling |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T11%3A09%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Restoration%20of%20autophagy%20in%20endothelial%20cells%20from%20patients%20with%20diabetes%20mellitus%20improves%20nitric%20oxide%20signaling&rft.jtitle=Atherosclerosis&rft.au=Fetterman,%20Jessica%20L&rft.date=2016-04-01&rft.volume=247&rft.spage=207&rft.epage=217&rft.pages=207-217&rft.issn=0021-9150&rft.eissn=1879-1484&rft_id=info:doi/10.1016/j.atherosclerosis.2016.01.043&rft_dat=%3Cproquest_pubme%3E1776086313%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1776086313&rft_id=info:pmid/26926601&rft_els_id=S0021915016300429&rfr_iscdi=true |